23andMe to delist from Nasdaq, deregister with SEC

A sign is posted in front of the 23andMe headquarters in Sunnyvale, California, on Feb. 1, 2024.

Justin Sullivan | Getty Images

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release.

The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.

The drugmaker came out on top following a bankruptcy auction for 23andMe, a once high-flying genetic testing company that filed for for Chapter 11 bankruptcy protection in March.

This is breaking news. Please refresh for updates.

Source

Technology

Amazon sellers boycott ads in policy change revolt: ‘We’re running out of f—ing margin’

April 15, 2026

An automated bar code reader scans packages prepared for shipping at an Amazon fulfillment center on Cyber Monday in Robbinsville, New Jersey, US, on Monday, Dec. 1, 2025. Michael Nagle | Bloomberg | Getty Images For Amazon sellers that account for over 60% of goods sold on the e-retailer’s sprawling marketplace, times would be tough […]

Technology

Nvidia’s long-awaited stock breakout is proof that patience pays off

April 15, 2026

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. The S & P 500 on Wednesday made a new intraday high for the year, as the rebound from the Iran war sell-off continued. At one […]

Technology

Tesla stock pops as Elon Musk touts chip progress

April 15, 2026

Tesla cars charge at a Tesla Supercharger station in Pasadena, California, March 30, 2026. Justin Sullivan | Getty Images Tesla stock rose more than 6% on Wednesday as CEO Elon Musk touted progress on the company’s forthcoming AI5 chip. Musk said in a post on his social network X on Wednesday that the chip has […]